PE/Cyanine7 anti-human CD21 Antibody
- 产品名称：
- PE/Cyanine7 anti-human CD21 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 354911
- 产品应用：
- 354911
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1632 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Cynomolgus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections4.
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Bj?rck P, et al. 1993. Eur. J. Immunol. 23:1771.
- Frémeaux-Bacchi V, et al. 1996. Eur. J. Immunol. 26:1497.
- Ling NR, et al. 1995. Clin. Exp. Immunol. 101:369.
- Wang, C, et al. 2011. BMC Immunol. 12:53. (IHC)
- Product Citations
-
- Woo MS, et al. 2021. iScience. 24(7):102752. PubMed
- Frasca D, et al. 2019. PLoS One. 14:e0219545. PubMed
- Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
- Sutton HJ, et al. 2021. Cell Reports. 34(6):108684. PubMed
- Shin JJ, et al. 2022. J Clin Immunol. :. PubMed
- Japp AS, et al. 2021. Cell. 184(3):827-839.e14. PubMed
- Punik J, et al. 2021. Cell Reports. 35(13):109320. PubMed
- Zabaleta N, et al. 2021. Cell Host Microbe. :. PubMed
- Christiansen M, et al. 2020. Front Immunol. 10:3022. PubMed
- Frasca D, et al. 2021. Front Immunol. 616650:12. PubMed
- RRID
- AB_2561576 (BioLegend Cat. No. 354911) AB_2561577 (BioLegend Cat. No. 354912)
- Structure
- Transmembrane protein, multiple SUSHI domains, approximate molecular weight 145 kD
- Distribution
-
Expressed on B cells, follicular dendritic cells, subsets of normal thymocytes and T cells, some epithelial cells
- Function
- Epstein-Barr virus receptor on B cells used for infection
- Interaction
- CD23, CD19, complement component 3, annexin VI, CD81, iC3b, complement receptor 1, interferon alpha 1
- Ligand/Receptor
- C3d, EBV
- Cell Type
- B cells, Dendritic cells, Epithelial cells, T cells, Thymocytes
- Biology Area
- Cell Biology, Complement, Costimulatory Molecules, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
- Molecular Family
- CD Molecules
- Antigen References
-
1. Kishimoto T, Eds. 1997. Leukocyte Typing VI. Garland Publishing Inc.
2. Moore MD, et al. 1987. Proc. Natl. Acad. Sci. USA 84:9194.
3. Szakonyi G, et al. 2001. Science 292:1725.
4. Weis JJ, et al. 1984. Proc. Natl. Acad. Sci. USA 81:881.
- Gene ID
- 1380 View all products for this Gene ID
- UniProt
- View information about CD21 on UniProt.org
